Clinical trials
Completed Observational Esophageal Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 4 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2 |
| Samsung Medical Center | 2 |
| Bristol-Myers Squibb | 1 |
| Changhai Hospital | 1 |
| Fudan University | 1 |
| Mian XI | 1 |
| Nanjing Medical University | 1 |
| National Cancer Institute (NCI) | 1 |
| OHSU Knight Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 24 |
| Esophageal Neoplasms | 5 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Postoperative Complications | 2 |
| Anastomotic Leak | 1 |
| Anus Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.